FORMULATIONS OF AN LSD1 INHIBITOR

The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseas...

Full description

Saved in:
Bibliographic Details
Main Authors WU, Huifang, ROCCO, William L, SHAH, Tanvi, LIU, Ying, LI, Mei
Format Patent
LanguageEnglish
Published 26.10.2022
Online AccessGet full text

Cover

More Information
Summary:The present application relates to pharmaceutical formulations and dosage forms of a lysine specific demethylase-1 (LSD1) inhibitor, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, including methods of preparation thereof, which are useful in the treatment of LSD1 mediated diseases such as cancer.
Bibliography:Application Number: ZA20180007865